BioSpace News Archive

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, today announced its participation in two upcoming international conferences – the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany,

HYLETE, Inc. is excited to announce the launch of a private placement offering in accordance with Regulation Crowdfunding (Reg CF) adopted by the Securities and Exchange Commission (SEC) through StartEngine.

Imaging Healthcare Specialists (IHS) extends Quality Patient Care and Operational Excellence by launching Imaging Block Lease Managed Services.

Dr. Jenny Klein-Sosa has joined mytaptrack® as their new Chief Research Officer (CRO).

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the domestic launch of the PediFoot Deformity Correction System, following 510 clearance by the U.S. Food and Drug Administration in August.

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced a clinical update on omburtamab for Desmoplastic Small Round Cell Tumor (“DSRCT”)

Amgen (NASDAQ:AMGN) in collaboration with the Duke Clinical Research Institute (DCRI) today announced plans to initiate the Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 inhibitors (cvMOBIUS) study—the first large-scale real-world study to assess lipid management and the impact of PCSK9 inhibitors on cardiovascular (CV) outcomes in clinical practice

Unitedcoatings Group launches today Lincotek Additive, aiming to provide a complete additive service offer for a reliable and sophisticated supply chain.

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that Dr. J. Joseph Kim, President and CEO, will present in a fireside discussion at the Stifel 2019 Healthcare Conference on Tuesday, November 19, 2019 at 10:20 a.m. Eastern Time in New York, NY. Dr. Kim will provide a business overview and update.

Medicinal Genomics Corp. (MGC), a pioneer in genomics and blockchain technology to improve the yield, safety and transparency of cannabis, today announced its partnership with Tagaca SRL as its distributor of record in Uruguay.